Extended half-life recombinant factor VIII treatment of hemophilia A in Brazil: an expert consensus statement Margareth Castro Ozelo; Sandra Vallin Antunes; Paula Ribeiro Villaca; Luciana Correa Oliveira; Ieda Solange Pinto; Claúdia Santos Lorenzato; Alessandra Nunes Loureiro Prezotti; Renato Mantelli Picoli;

Efficacy, safety and satisfaction of using emicizumab in hemophilia A patients without factor VIII inhibitors: A systematic review Isabela de Oliveira Araujo; Lucas Fernandes Suassuna; Isabela Lima dos Santos; Daniela de Oliveira Werneck Rodrigues;

Minor surgical procedures during immune tolerance induction in people with hemophilia A and inhibitors: results from the Brazilian Immune Tolerance (BrazIT) study cohort Ricardo Mesquita Camelo; Maíse Moreira Dias; Suely Meireles Rezende;